Bausch + Lomb Corporation (BLCO) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Vaughan, ON, Canada. Le PDG actuel est Brenton L. Saunders.
BLCO a date d'introduction en bourse 2022-05-06, 13,500 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $5.92B.
Bausch + Lomb Corporation is a global eye health company founded in 1853 and headquartered in Vaughan, Canada. The company operates through three primary segments: Vision Care and Consumer Health Care, which includes contact lenses across all wearing modalities, lens care solutions, and over-the-counter eye care products; Ophthalmic Pharmaceuticals, offering both proprietary and generic medications for conditions such as glaucoma, ocular hypertension, and retinal diseases; and Surgical, which provides advanced surgical instruments, intraocular lenses, and equipment for cataract and retinal procedures. Together, these segments enable Bausch + Lomb to serve patients across the complete spectrum of eye health, from routine vision correction to complex surgical interventions.
